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Available online 1 July 2005Human HDR (hypoparathyroidism, deafness and renal dysplasia)-
syndrome is caused by haploinsufficiency of zinc-finger transcription
factor GATA3. The hearing loss due to GATA3 haploinsufficiency has
been shown to be peripheral in origin, but it is unclear to what extent
potential aberrations in the outer hair cells (OHCs) contribute to this
disorder. To further elucidate the pathophysiological mechanism
underlying the hearing defect in HDR-syndrome, we investigated
the OHCs in heterozygous Gata3-knockout mice at both the
functional and morphological level. While the signal-to-noise ratios
of distortion product otoacoustic emissions (DPOAE) in wild type
mice did not change significantly during the first half-year of live,
those in the heterozygous Gata3 mice decreased dramatically. In
addition, both light microscopic and transmission electron micro-
scopic analyses showed that the number of OHCs containing vacuoles
was increased in the mutants. Together, these findings indicate that
outer hair cell malfunctioning plays a major role in the hearing loss
in HDR-syndrome.
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In 1992, HDR-syndrome was first described as a new clinical
entity, comprising hypoparathyroidism, deafness and renal dyspla-
sia (Bilous et al., 1992).
The sensorineural hearing loss in HDR patients can be both
symmetric or asymmetric, and as tested by auditory brainstem
response (ABR), conditioned orientation reflex tests or pure tone
audiometry, it ranges in level from 40 dB to 105 dB (Bilous et al.,
1992; Fujimoto et al., 1999; Hasegawa et al., 1997; Lichtner et al.,
2000; Muroya et al., 2001). Although it is clear that hearing loss in
HDR is usually somewhat more severe at the higher end of the
frequency spectrum (Lichtner et al., 2000; Muroya et al., 2001), no
systematic audiometric evaluation has yet been made, and the exact
pathophysiological mechanism causing the hearing defect remains
largely unknown. Genetically, HDR-syndrome is caused by
haploinsufficiency of zinc finger transcription factor GATA3
(Van Esch and Bilous, 2001; Van Esch and Devriendt, 2001; Van
Esch et al., 2000), which in mice is essential for development of
several tissues and organs including the lymphatic system, the
sympathetic nervous system, brain, kidney, jaw and inner ear (Lim
et al., 2000; Pandolfi et al.; 1995, Pata et al., 1999; Ting et al.,
1996; van Doorninck et al., 1999; Zheng and Flavell, 1997).
During development, human and murine GATA3 is prominently
expressed in virtually all cell types of the inner ear including inner
hair cells (IHCs), outer hair cells (OHCs) and supporting cells as
well as in various cell types of the central auditory system
including neurons in the superior olive and inferior colliculus
(Debacker et al., 1999; Karis et al., 2001; Lawoko-Kerali et al.,
2002; Rivolta and Holley, 1998; van der Wees et al., 2004; van
Doorninck et al., 1999).
In line with HDR-syndrome in humans, heterozygous Gata3
mice show an elevation in their Auditory Brainstem Response-
thresholds. Thresholds are elevated by approximately 30 dB, while
no interpeak latency differences can be found. In addition, Gata3
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young ages onwards, without any morphological abnormalities in
the central nervous system. This led us to conclude that hearing
loss due to GATA3 haploinsufficiency is peripheral in origin (van
der Wees et al., 2004). Building upon the above-mentioned
findings, and considering the fact that at light microscopical level
outer hair cells (OHCs) degenerated first before subsequent loss of
inner hair cells (IHC), pillar cells (PC) and nerve fibers (NF), we
hypothesized that OHC malfunctioning could be an important
factor causing hearing loss in GATA3 haploinsufficiency.
The most accurate measure for testing OHC function is
otoacoustic emissions (OAEs) (Schrott et al., 1991). Otoacoustic
emissions have been used in mice auditory research for a variety of
purposes, among others to study age related hearing loss – AHL –
(Jimenez et al., 1999; Parham, 1997; Parham et al., 1999), noise
induced hearing loss – NIHL – (Jimenez et al., 2001; Vazquez et
al., 2001) and effects of hypothyroidism on OHCs (Li et al., 1999).
Moreover, OAEs have also been used for auditory phenotyping
and to study effects of genetic mutations on the auditory system
(Huang et al., 1995, 1998; Konrad-Martin et al., 2001).
To shed light on the potential role of dysfunction of OHCs in
the hearing loss found in HDR patients, we investigated the
function of these cells in heterozygous Gata3 mice. We inves-
tigated functioning of their OHCs by measuring the distortion
product otoacoustic emissions (DPOAE) and by further analyzing
the morphology of these cells at both the light microscopic and
electron microscopic level at young ages (1 to 2 months).Materials and methods
Mouse lines/subjects
Heterozygous Gata3 knockouts (129/C57BL/6 GATA3-
nlsLacZ mice bred 6 to 8 times into FVB/N background) were
compared to wild type mice from the same litter. Animal
experiments were performed in accordance with the ‘‘Principles
of laboratory animal care’’ (NIH publication No. 86–23, revised
1985) and the guidelines approved by the Erasmus University
animal care committee (DEC; protocol No. 138-02-01).
Light microscopy and electron microscopy
Outer hair cell loss was analyzed at the light microscopic level
in 24 cochleae of 7 heterozygous Gata3 and 7 wild type mice, in
the age range between 1 and 15 months. The animals were deeply
anesthetized with Nembutal and perfused transcardially with 4%
paraformaldehyde in 0.1 M phosphate buffer.
Cochleae were post-fixed in 1% osmium tetroxide for 1 h,
embedded in plastic (Durcupan from Fluka, Buchs, Switzerland),
and dissected into 10 Fquarter_ turns (Bohne and Harding, 1997). In
the material of each consecutive Fquarter_, both the length of the
organ of Corti and the number of present OHCs were determined.
A total of 11 cochleae (left and right ears) obtained from 3 mice
of each genotype (of which one was 1 month old and two were 2
months old) were used for analysis of differences between
heterozygous and wild type mice at light microscopical level.
Cochlear pieces containing those sections of the organ of Corti that
are responsive to approximately 4, 16 and 32 kHz were used for
histological analysis (Ou et al., 2000). Semithin slices (1 Am thick)
were cut on a Leica Reicherts Ultratome and counterstained with aToluidin blue-staining containing 1% Toluidin blue, 1% Methylene
blue, 0.2% Sodiumhydroxide, 1% Borax, 30% Ethanediol Ethyl-
eneglycol and 70% MilliQ water. Slices were examined under a
Leica DM-RB microscope. Per cochlear piece, 50 to 163 slices
were examined. The number of OHCs containing vacuoles was
scored and entered in Excel data files, which were subsequently
imported into an SPSS-data file. Statistical analysis of histological
data was done using SPSS for Windows version 11.0. An effect
was considered significant when P < 0.02. Non-parametric
(Mann–Whitney) tests were used to analyze the difference in
numbers of outer hair cells containing vacuoles between geno-
types. Apart from this, the effect of age and location of the OHC in
the cochlea on this difference was analyzed.
In order to assess possible additional signs of (outer) hair cell
degeneration, such as mitochondrial changes, changes in endo-
plasmatic reticulum and disappearance of ribosomes ultrathin slices
were cut for electron microscopy, and contrasted with uranyl
acetate and lead citrate (Oei et al., 2003) of inner ears from three 2-
month-old mice for each genotype. Slices were analyzed using a
Philips CM100 electron microscope.
DPOAE-test procedure
Per age group, genotype and gender at least 5 mice were
subjected to DPOAE measurements (i.e. at least 20 mice were
examined per age group). Measurements were performed both
longitudinally and transversally (32 mice were tested once, 25 mice
twice, 9 mice trice and 7 mice four times). Animals were
anesthetized with a mixture of 5% Fluothane, N2O and O2. After
induction of anesthesia, mice were placed on a heating pad
(Thermocomfort, Brisk BV, Venray, The Netherlands), to maintain
constant body temperature. In each mouse, the right and left ears
were consecutively tested. Cerumen obstruction and infection were
excluded prior to experiments by otoscopically inspecting ear
canals and eardrums. Mice suffering from obvious outer or middle
ear problems were temporarily excluded from experiments. To
equalize the anesthesia induced increase in middle ear pressure, the
pars flaccida of the tympanum was perforated using a Microlance\
needle. The success rate of this procedure was high. Occasionally,
however, the perforation was unsuccessful or closed during
measurements, resulting in a decrease of signal-to-noise ratios of
emissions. If so, a second tympanocentesis was performed.
Repeated measurements (and ear drum perforations) in individual
mice did not influence DPOAE levels; an illustrative example of
this is given in Fig. 1. Signal-to-noise ratios of two 5-month-old
mice are compared, one after a single, and the other after four test
sessions. Next, foam stripped Etymotic\ ER10C-14C ear tips
were fitted in the external ear canals to enable recording of
DPOAE.
DPOAE measurements
2f1–f2 DPOAEs were measured using a commercially avail-
able recording system (DP 2000 – Starkey). After introduction of
the probe and prior to actual recordings, calibration of the
stimulation conditions was done over a 0.1–20 kHz frequency
range. The primary frequency ratio (f2/f1) was 1.2 (Le Calvez et
al., 1998b). The targeted primary tone levels, L1/L2, were 65/55
dB SPL. Data were collected with f2 at 6.8, 8.0, 9.5, 11.3, 13.5 and
16.0 kHz. All experiments were performed in a quiet but not sound
treated room. Recordings were repeated (at least 6 times).
Fig. 1. DPOAE signal-to-noise ratios (dB) of two 5-month-old wild type
mice; open circles indicate results after a single measurement, closed
triangles represent results after four test sessions. Data for both ears are
represented. Repeated measurements and paracentesis in individual mice
did not influence DPOAE levels.
Table 1
Number of mice per age group, genotype and frequency (f2) after selection
of data on DPOAE recording-quality criteria
Age
(months)
f2 frequencies (kHz) and genotypes
6.8 8.0 9.5 11.3 13.5 16.0
wt ht wt ht wt ht wt ht wt ht wt ht
1.0 8 9 9 11 9 11 1 6 9 9 11
2.0 7 10 7 11 7 11 2 2 6 10 6 10
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DPOAE data processing was done using SPSS for Windows
version 10.0. Raw data, as stored in the database of the DPOAE
recording system, were imported into SPSS-data files. Data were
included for statistical analysis after a strict selection as to quality
of calibration curves of both stimulus channels, on noise floor and
stimulus condition quality during recordings. Symmetry criteria of
the calibration curves of both loudspeakers in the probe were used
for selection of good quality recordings. Furthermore, recordings
with calibration curves showing a probable air leakage or occlusion
of probe channels by the ear canal wall were excluded, as were
recordings with background noise levels over 2 dB SPL and
recordings with stimulation levels differing too much from targeted
levels (more than 15 dB). Finally, only recordings with primary
tone level differences ranging from 1 to 12 dB were included.
Table 1 displays the number of mice per age group, genotype and
frequency (f2) after strict selection of data. For the f2 = 11.3 kHz,
target levels of the primaries often failed to meet the selection
criteria. Therefore, this frequency was excluded from further
statistical analysis. Subsequently, of every individual mouse, the
emission with the best signal-to-noise ratio per age, per frequency,
and per ear was selected for analysis. Since each individual mouse
was measured on both ears, we analyzed ear effects prior to further
analyses. Within individual mice, a significant correlation existed
between right and left ears (Pearson’s correlation coefficient = 0.81,
significance < 0.0005). Therefore, data were aggregated for each
mouse (means of right and left ears), at each age and frequency, for
further analysis of genotype and gender influence. Statistical
analysis of DPOAE data was done using SPSS for Windows
version 10.0. An effect was considered significant when P < 0.02.
Effects of genotype on signal-to-noise ratio’s were analyzed, as
were age effects, and gender effects.3.0 9 12 10 12 10 12 3 2 9 12 10 12
4.0 9 8 10 8 10 8 5 3 6 8 9 8
5.0 11 10 11 11 11 11 5 11 10 11 11
6.0 11 10 11 10 11 10 3 4 11 10 11 10
7.0 5 8 7 9 7 9 3 5 9 7 9
For the f2 = 11.3 kHz, only a limited number of data met the selection
criteria, therefore, this frequency was excluded from further statistical
analysis (wt; wild type, ht; heterozygous).Results
Light microscopy
Quantitative analyses of the OHCs revealed a progressive loss
of apical outer hair cells in heterozygous mice from 1 monthonward, significantly preceding and exceeding loss in wild types.
At the same time, some degeneration occurred at the basal turn of
the cochlea, but the level of this process was comparable to that in
wild type mice. By the age of 9 months, in mutants, nearly all
OHCs had disappeared, while in the wild types, OHCs were still
only affected at the base of the cochlea (Figs. 2A and B). Thus,
Gata3 haploinsufficiency induced degeneration started at the apex
and ultimately progressed into the middle turns of the cochlea.
To investigate effect of Gata3 haploinsufficiency on the
morphological structure of outer hair cells from heterozygous
Gata3 mice, we analyzed semithin plastic sections and compared
them to sections from wild types. We examined 1151 slices,
representing 11 cochleae of 6 mice, at light microscopic level. The
estimated width of OHCs in the cochlear regions examined in our
study was approximately 5 Am, so that a maximum of 5 semithin
slices per OHC may have been included in histological analysis.
No compelling differences between heterozygous mice and wild
type controls were found other than numbers of OHCs showing
vacuoles. OHCs in heterozygous mice contained vacuoles more
often than those in controls, an illustrative example of this can be
seen in Figs. 3A and B. In heterozygous mice, vacuoles were found
throughout the cell, whereas when present in wild type mice, they
were predominantly seen in the apical region.
The difference in numbers of OHCs containing vacuoles was
age-dependent: at 1 month of age, this number significantly
differed between genotypes for the first row of OHCs only
(Mann–Whitney, P < 0.02), whereas at 2 months of age, the
difference was significant (Mann–Whitney, P < 0.02) for all three
rows (see Fig. 4A).
Analysis within genotypes demonstrated an increase in the
number of cells with vacuoles in the second as compared to the
first month in heterozygous mice. This increase was significant for
all three rows of OHCs at P < 0.02 (see Fig. 4A). In wild types,
numbers of cells containing vacuoles were low constantly over the
observed age range.
The significant age-dependent increase in affected OHCs in
heterozygous mice is mainly due to the highly significant increase
in vacuoles in all rows of OHCs in the apical pieces (Mann–
Whitney, P < 0.001). In the mid-cochlear pieces, a similar trend
was seen, but no significant differences could be demonstrated (see
Fig. 4B).
In conjunction, our data show that GATA3 haploinsufficiency
induces OHC degeneration, especially in the apical regions of the
Fig. 3. Vacuolization in Gata3 heterozygous OHCs. Plastic sections of normal OHCs from a 2-month-old wild type mouse (A) and of abnormal OHCs, with
vacuoles in all three OHC rows, from a 2-month-old heterozygous Gata3 mouse (B). Electronmicroscopy of a normal wild type (C) and a Gata3 +/ OHC (D)
shows multiple vacuoles in the mutant OHC that otherwise looks normal. Panel E is a magnification of panel D and shows the irregular shape of the unfilled
vacuoles that have a single layer membrane. Scale bars are 2 Am for panels A–D and 0.5 Am for panel E.
Fig. 2. Presence of outer hair cells (OHC) in cochleae of wild type (upper panel) and heterozygous (lower panel) Gata3 mice of 1, 2, 5, 9 and 15 months of age.
Markers indicate the percentage of cells present in the 10 different cochlear pieces, plotted against the distance to the apex of the analyzed cochlear part. Hair
cells responsive to 4 kHz, 8 kHz, 16 kHz and 32 kHz tones are found at approximately 25%, 40%, 60% and 75% distance from the apex, respectively (Ou et al.,
2000). OHCs in both the apical and basal cochlear regions degenerate in heterozygous mice, and progressively so with age. Wild type controls in contrast, are
only affected by (normal) loss of basal outer hair cells (previously, data were presented partially in van der Wees et al., 2004).
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Fig. 4. (A) Percentages of cells containing vacuoles versus age and
genotype (wt; wild type, ht; heterozygous). Numbers of OHCs containing
vacuoles significantly differed between genotypes for the first row of OHCs
at 1 month of age (^), at 2 months of age, this difference was significant for
all three rows (o). Analysis within genotypes demonstrated an increase in
the number of cells with vacuoles in the second as compared to the first
month in heterozygous mice. This increase was significant for all three rows
of OHCs at P < 0.02 (*). In wild types, less than 10% of cells contained
vacuoles. Error bars indicate 95% confidence intervals. (B) Percentages of
cells containing vacuoles versus age per genotype and cochlear localization.
Analysis of influence of cochlear localization demonstrated the increase in
the number of cells with vacuoles as described in heterozygous mice in Fig.
2A, to be due to the highly significant increase in vacuoles in all rows of
OHCs in the apical pieces in the second as compared to the first month of
age (*) (Mann–Whitney, P < 0.001). No significant differences could be
demonstrated in the mid-cochlear or basal pieces. Numbers of cells
containing vacuoles in the cochlear apex, however, differed significantly
between genotypes, both at 1 (o) and 2 months (^) of age (Mann–Whitney,
P < 0.02). Error bars indicate 95% confidence intervals. A = apical, M =
mid-cochlear, B = basal.
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effects increase with increasing age.
Electron microscopy
To closer examine the nature of the observed vacuoles in the
OHCs, we investigated them at the ultrastructural level. The
vacuoles were irregularly shaped and surrounded by a single layer
membrane (Figs. 3D and E). The OHCs did not show any sign of
apoptosis or immediate cell death such as pyknotic nuclei orabnormal mitochondria. Thus, the first sign of GATA3-driven
degeneration of OHCs seems to be the appearance of irregularly
shaped vacuoles, which can be observed at both the light
microscopic level and at electron microscopic level.
Otoacoustic emissions
Outer hair cell functionality was examined by measuring
DPOAE levels in both Gata3 heterozygous and wild type mice
at various ages. DPOAE signal-to-noise ratios differed signifi-
cantly between Gata3 heterozygous mice and wild types when data
were pooled over all f2’s and ages (Mann–Whitney Test, P <
0.001) (Fig. 5). When separate ages and f2’s were analyzed, this
significance was consistent (at the P < 0.02 level) for groups larger
than 6 (see Table 1), with the sole exception of 7-month-old mice
at 9.5 kHz (P = 0.023). Emission levels in the f2 frequency range
from 6.8 kHz to 16.0 kHz remained fairly constant in wild type
mice during the first 7 months of life, whereas in the mutants,
signal-to-noise ratios rapidly decreased during this period (Figs. 5
and 6). At 7 months of age, signal-to-noise ratios of DPOAEs in
heterozygous mice no longer differed from 0 dB. Signal-to-noise
ratios did not differ significantly between genders for pooled data
(t test, P > 0.2), or within specific age groups (t tests, P > 0.02).
In sum, our acousto-physiological analyses demonstrated a
rapid deterioration of OHC functionality in Gata3 heterozygous
mice, starting apically in the cochlea and progressing onto its base.Discussion
Here, we show that young heterozygous Gata3 mice generate
abnormal Distortion Product Oto-Acoustic Emissions (DPOAEs)
and that their outer hair cells (OHCs) are commonly affected by
vacuoles. Together, these data raise the possibility that dysfunc-
tional OHCs form one of the prime causes of hearing loss in these
mutants. Since HDR patients, who suffer from the same
haploinsufficiency as these mouse mutants, suffer from hearing
loss as well, this pathological mechanism may also hold for HDR
patients.
Outer hair cells are affected by both histological and physiological
aberrations
Otoacoustic emissions (OAEs) are the best means for testing
OHC function in vivo (Schrott et al., 1991). In our present study,
distortion product otoacoustic emissions were recorded in 1–7-
month-old Gata3 heterozygous mice and in age- and sex-matched
controls. In both genotypes, the loudest emissions were found in
the higher end of the frequency range (6.8 kHz–16 kHz). Emission
levels decreased rapidly over time in heterozygous knockout mice,
whereas in wild type controls, they remained fairly constant during
the first 7 months of life. Signal-to-noise emission levels in the
FVB/N controls in this study are equal to, or even slightly better
than emission levels in the CBA/J mouse model, which is
considered a well hearing strain until relatively late in life (Parham
et al., 1999). During DPOAE recordings, we used gas anesthesia,
since this type of narcosis provides flexibility (e.g. short-term
anesthesia), despite the known increase in middle ear pressure
caused by N2O, necessitating paracentesis. Moreover, we demon-
strated that repeated measurements in itself did not influence
DPOAE levels (Fig. 1). Thus, in contrast to the commonly used
Fig. 5. 98% confidence intervals of DPOAE signal-to-noise ratios (dB SPL) at f2’s 6.8–16.0 kHz for wild type (discontinuous line) and heterozygous
(continuous line) mice aged 1 to 7 months. At all ages and frequencies, emissions in wild types were stronger than in heterozygous mice. At 7 months of age,
hardly any emissions could be generated in heterozygous knockouts, whereas signal-to-noise ratios in wild types remained fairly constant. Signal-to-noise
ratios at 11.3 kHz are not represented graphically, since statistical analysis was unreliable due to small numbers of data (see Table 1).
Fig. 6. Signal-to-noise ratios (dB SPL) of 1–7-month-old wild type and heterozygous mice in the f2 frequency range 6.8 to 16.0 kHz. During the first 7 months
of life, emission levels remain fairly constant in wild type mice, whereas in heterozygous mice, signal-to-noise ratios rapidly decrease.
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1999; Jimenez et al., 2001; Konrad-Martin et al., 2001), gas
anesthesia may be quite feasible for (longitudinal) DPOAE
recordings.
Heterozygous mice also differed from controls in numbers of
OHCs containing vacuoles, increasingly so with age. Curiously, no
gross abnormalities were found in other cochlear cell types
expressing GATA3. Further histological analysis of OHCs by
electron microscopy excluded other changes at the cellular level
such as apoptosis. Vacuoles are frequently seen as the first signs of
(hair) cell death (Vetter et al., 1996). At 2 months of age, the
numbers of outer hair cells containing vacuoles in heterozygous
mice were especially high in the apical region of the cochleae,
which is responsive to frequencies of approximately 4 kHz (Ou et
al., 2000), whereas in the middle (responsive to 16 kHz) and basal
regions (responsive to 32 kHz), these numbers remained low.
These findings are in agreement with the outcomes of the DPOAE
measurements, which showed that the loudest emissions were
found in the vacuole-free frequency regions. Thus, although the
current data do not allow us to conclude that there is a direct causal
relation between the deficits in DPOAEs and the occurrence of
vacuoles in the OHCs, both findings suggest that functional
deficits in OHCs may contribute to hearing loss in HDR-syndrome.
Role of outer hair cells in hearing loss in HDR
Our findings that GATA3 haploinsufficiency induces an age-
dependent loss of OHC function as well as concomitant
histological anomalies in OHCs raise the question as to whether
the OHCs can be held solely responsible for the hearing loss in
HDR-syndrome. Although at present it is not possible to answer
this question conclusively, several findings suggest that we cannot
exclude this possibility either.
First, deficits in both DPOAEs and ABRs start to occur in the
first few months of life (see also van der Wees et al., 2004).
Second, DPOAE signal-to-noise ratios in heterozygous Gata3
mice as compared to controls are lower for all f2 frequencies in the
6.8–16.0 kHz range, agreeing with the fact that ABR-thresholds in
these mice were elevated for all tested frequencies (4–32 kHz) in
the age range of 1–19 months as compared to controls. Moreover,
ABR-thresholds are worse at 4 kHz, compared to 16 kHz for ages
up to 19 months, this corresponds to lower DPOAE signal-to-noise
ratio’s in the lower end of the frequency range described here.
Third, ABR-thresholds in heterozygous mice are on average
elevated by approximately 30 dB (van der Wees et al., 2004),
which agrees well with numerous other animal models in which
there is a presumptive selective deficit of the OHCs. For example,
Kanamycin sulfate treatment, causing complete loss of OHCs, with
preservation of IHCs, results in threshold shifts of 40 dB and more
in chinchillas (Woolf et al., 1981). In the same species, the first
approximate 30 dB of noise-exposure induced permanent threshold
shifts is induced by primarily outer hair cell losses (Hamernik et
al., 1989). On the other hand, neomycin in combination with
acoustic trauma causes decreases in cochlear sensitivity amounting
up to 62 dB, averaged across all frequencies, in guinea pigs with
losses of cochlear OHCs close to 100% (Brown et al., 1978).
Unfortunately, the effect of the used treatment on other cochlear
cell types was not described. Finally, homozygous Kit W-v mice
(Wv/Wv), which have normal IHCs but lack 98% of cochlear
OHCs, have an elevation of ABR-thresholds up to about 50 dB, as
compared to control mice (Schrott et al., 1990).It should be noted that the exact correlation between DPOAEs
and ABR-thresholds remains to be established. DPOAEs were
below the level of detection in laboratory animals such as mice and
chinchilla’s when ABR-threshold shifts exceeded approximately
40 dB (e.g. Kakigi et al., 1998; Le Calvez et al., 1998a), however,
when tentatively correlating DPOAE levels to ABR-thresholds
variances were fairly large and no significant correlation was
established so far. When considering our data, we find that the best
DPOAE signal-to-noise ratios in heterozygous Gata3 mice were
recorded in the upper half of the tested frequency spectrum during
the first months, when ABR-thresholds of corresponding frequen-
cies (8 and 16 kHz) ranged approximately between 30 and 50 dB
SPL. Moreover, in wild type controls, DPOAE signal-to-noise
ratios were high and remained fairly constant over the time span
presented in this paper, where ABR-thresholds did on average not
exceed 40 dB SPL during the first 7 months of life for the 4–16
kHz range.
Thus, taken together, we can conclude that it appears likely that
OHC dysfunction caused by GATA3 haploinsufficiency contrib-
utes to hearing loss in HDR-syndrome, but it remains to be
demonstrated whether it is the sole cause.
Conclusions
GATA3 haploinsufficiency is known to cause hearing loss in
both humans affected by the HDR-syndrome and mice. The goal of
the present study was to elucidate the role of outer hair cells in this
process. We demonstrated that GATA3 haploinsufficiency causes a
rapid deterioration of OHC function in mice. Apical OHCs show
early signs of cell degeneration in affected mice as young as 1 to 2
months in that they exhibit multiple vacuoles and produce
abnormal emissions. We conclude that outer hair cell malfunction-
ing can play a major role in the hearing loss in HDR-syndrome.Acknowledgments
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